William Blair & Company
IMPV

William Blair & Company’s Imperva, Inc. IMPV Stock Holding History

William Blair & Company’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,000
Closed -$48K – 2083
2013
Q4 		$48K Buy
+1,000
New +$42.1K ﹤0.01% 1958

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

William Blair & Company's IMPV Position: Q1 2017 in Review

William Blair & Company sold out of Imperva, Inc. (IMPV) in Q1 2017, closing a stake of 19,159 shares — an estimated $736K sold.

William Blair & Company first reported a position in IMPV in Q3 2013 and held it in 14 quarters. The position peaked at $11.3M in Q1 2014. 182 funds tracked by Wall St. Rank hold IMPV as of Q1 2017.

  • William Blair & Company reported no remaining Imperva, Inc. position as of Q1 2017 after selling out during the quarter.
  • William Blair & Company sold 19,159 Imperva, Inc. shares in Q1 2017, an estimated $736K.
  • William Blair & Company first reported a position in Imperva, Inc. in Q3 2013 and held it in 14 quarters.
  • William Blair & Company's Imperva, Inc. position peaked at $11.3M in Q1 2014.
  • 182 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2017.

Based on William Blair & Company's 13F filing for Q1 2017, filed 10 May 2017.